Ethyl alcohol and dilative cardiomyopathy

Area of Science:

• Cardiology
• Toxicology
• Internal Medicine

Background:

• Ethanol consumption is a significant factor in developing dilative cardiomyopathy.
• Alcohol's direct and indirect effects via metabolites impact cardiac and neuroendocrine systems.
• Understanding the complex pathophysiology of alcoholic cardiomyopathy is crucial for effective management.

Purpose of the Study:

• To elucidate the complex clinical and paraclinical manifestations of ethanol-induced dilative cardiomyopathy.
• To investigate the impact of alcohol and its metabolites on the human myocardium and neuroendocrine system.
• To highlight the sensitivity of the cardiac conduction system and working myocardium to ethanol's effects.

Main Methods:

• Clinical assessment of patients with suspected ethanol-induced cardiomyopathy.
• Paraclinical investigations including electrocardiography and echocardiography.
• Evaluation of cardiac function, including systolic and diastolic parameters, and relaxation times.

Main Results:

• Significant prevalence of ventricular and atrial arrhythmias, indicating high conduction system sensitivity.
• Evidence of impaired systolic and diastolic function in the working myocardium.
• Demonstration of nitroglycerine-resistant isovolumetric relaxation time, suggesting specific diastolic dysfunction.

Conclusions:

• Ethanol-induced dilative cardiomyopathy presents with complex cardiac abnormalities.
• Both direct alcohol toxicity and metabolite actions contribute to myocardial and neuroendocrine dysfunction.
• The findings underscore the profound impact of chronic alcohol use on cardiac structure and function.